Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
AI and Machine Learning
Biotech
Chugai drops only AI-assisted antibody from pipeline
With the scrapping of phase 1 chronic disease candidate BRY10, Chugai now has no antibodies designed using its AI platform in clinical trials.
Darren Incorvaia
Jan 30, 2026 10:55am
AI-driven Formation snaps up oral autoimmune asset in $500M play
Jan 29, 2026 1:20pm
Qilu inks $120M, AI-enabled cardiometabolic pact with Insilico
Jan 27, 2026 5:20am
Takeda leader says AI gave early-stage asset a 'phoenix' rebirth
Jan 13, 2026 6:16am
Lilly, Nvidia form new AI co-innovation lab with $1B investment
Jan 12, 2026 10:00am
GSK inks model deal in $50M bet on Noetik's cancer AI platform
Jan 8, 2026 10:30am
